Stocksigma LogoStocksigma Logo

Aspira Pathlab Approves Rights Issue to Raise Up to Rs 65 Crore

Aspira Pathlab & Diagnostics' Board approved a fundraise of up to Rs 65 crore via a Rights Issue of equity shares or other convertible instruments on 12th

Aspira Pathlab Approves Rights Issue to Raise Up to Rs 65 Crore

Aspira Pathlab & Diagnostics Ltd 路 Outcome 路 12 Sept 2026, 10:18 pm

Aspira Pathlab Approves Rights Issue to Raise Up to Rs 65 Crore Aspira Pathlab & Diagnostics' Board approved a fundraise of up to Rs 65 crore via a Rights Issue of equity shares or other convertible instruments on 12th Sep'26, subject to shareholder and regulatory approvals. The Board constituted a Rights Issue Committee, chaired by Nikunj Velji Mange, to finalize issue terms, including the record date, issue price, and rights entitlement ratio.

Original exchange filing (PDF)

More announcements from Aspira Pathlab & Diagnostics Ltd

All Aspira Pathlab & Diagnostics Ltd announcements